60098 Federal Register / Vol. 62, No. 215 / Thursday, November 6, 1997 / Notices

Contact Person: Sharee Pepper, Ph.D.,

Scientific Review Administrator, Review

Branch, DEA, NIDDK, Natcher Building,

Room 6as–25E, National Institutes of Health,

Bethesda, Maryland 20892–6600, Phone:

(301) 594–7798.

Purpose/Agenda: To review and evaluate

grant applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personnel

information concerning individuals

associated with the applications and/or

proposals, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.847–849, Diabetes, Endocrine

and Metabolic Diseases; Digestive Diseases

and Nutrition; and Kidney Diseases, Urology

and Hemotology Research, National Institutes

of Health)

Dated: October 28, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–29367 Filed 11–5–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS

(Formerly: National Institute on Drug

Abuse, ADAMHA, HHS)

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be identified as such at the end of the

current list of certified laboratories, and

will be omitted from the monthly listing

thereafter.

This Notice is now available on the

internet at the following website: http:/

/www.health.org

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, Room

13A–54, 5600 Fishers Lane, Rockville,

Maryland 20857; Tel.: (301) 443–6014.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACL Laboratory, 8901 W. Lincoln Ave.,

West Allis, WI 53227, 414–328–7840

(formerly: Bayshore Clinical

Laboratory)

Aegis Analytical Laboratories, Inc., 345

Hill Ave., Nashville, TN 37210, 615–

255–2400

Alabama Reference Laboratories, Inc.,

543 South Hull St., Montgomery, AL

36103, 800–541–4931/334–263–5745

American Medical Laboratories, Inc.,

14225 Newbrook Dr., Chantilly, VA

22021, 703–802–6900

Associated Pathologists Laboratories,

Inc., 4230 South Burnham Ave., Suite

250, Las Vegas, NV 89119–5412, 702–

733–7866/800–433–2750

Associated Regional and University

Pathologists, Inc. (ARUP), 500 Chipeta

Way, Salt Lake City, UT 84108, 801–

583–2787/800–242–2787

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little

Rock, AR 72205–7299, 501–202–2783

(formerly: Forensic Toxicology

Laboratory Baptist Medical Center)

Cedars Medical Center, Department of

Pathology, 1400 Northwest 12th Ave.,

Miami, FL 33136, 305–325–5784

Clinical Reference Lab, 8433 Quivira

Rd., Lenexa, KS 66215–2802, 800–

445–6917

CompuChem Laboratories, Inc., 1904

Alexander Drive, Research Triangle

Park, NC 27709, 919–572–6900 / 800–

833–3984 (formerly: CompuChem

Laboratories, Inc., A Subsidiary of

Roche Biomedical Laboratory, Roche

CompuChem Laboratories, Inc., A

Member of the Roche Group)

Cox Health Systems, Department of

Toxicology, 1423 North Jefferson

Ave., Springfield, MO 65802, 800–

876–3652 / 417–269–3093 (formerly:

Cox Medical Centers)

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, P.O. Box

88–6819, Great Lakes, IL 60088–6819,

847–688–2045 / 847–688–4171

Diagnostic Services Inc., dba DSI, 4048

Evans Ave., Suite 301, Fort Myers, FL

33901, 941–418–1700 / 800–735–5416

Doctors Laboratory, Inc., P.O. Box 2658,

2906 Julia Dr., Valdosta, GA 31604,

912–244–4468

DrugProof, Division of Dynacare/

Laboratory of Pathology, LLC, 1229

Madison St., Suite 500, Nordstrom

Medical Tower, Seattle, WA 98104,

800–898–0180 / 206–386–2672

(formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle,

Inc.)

DrugScan, Inc., P.O. Box 2969, 1119

Mearns Rd., Warminster, PA 18974,

215–674–9310

ElSohly Laboratories, Inc., 5 Industrial

Park Dr., Oxford, MS 38655, 601–236–

2609

General Medical Laboratories, 36 South

Brooks St., Madison, WI 53715, 608–

267–6267

Harrison Laboratories, Inc., 9930 W.

Highway 80, Midland, TX 79706,

800–725–3784 / 915–563–3300

(formerly: Harrison & Associates

Forensic Laboratories)

Jewish Hospital of Cincinnati, Inc., 3200

Burnet Ave., Cincinnati, OH 45229,

513–569–2051

LabOne, Inc., 8915 Lenexa Dr., Overland

Park, Kansas 66214, 913–888–3927 /

800–728–4064 (formerly: Center for

Laboratory Services, a Division of

LabOne, Inc.)

Laboratory Corporation of America, 888

Willow St., Reno, NV 89502, 702–

334–3400 (formerly: Sierra Nevada

Laboratories, Inc.)

Laboratory Corporation of America

Holdings, 69 First Ave., Raritan, NJ

08869, 800–437–4986 / 908–526–2400
Federal Register / Vol. 62, No. 215 / Thursday, November 6, 1997 / Notices 60099

(formerly: Roche Biomedical

Laboratories, Inc.)

Laboratory Specialists, Inc., 1111

Newton St., Gretna, LA 70053, 504–

361–8989 / 800–433–3823

Marshfield Laboratories, Forensic

Toxicology Laboratory, 1000 North

Oak Ave., Marshfield, WI 54449, 715–

389–3734 / 800–331–3734

MedExpress/National Laboratory

Center, 4022 Willow Lake Blvd.,

Memphis, TN 38118, 901–795–1515 /

800–526–6339

Medical College Hospitals Toxicology

Laboratory, Department of Pathology,

3000 Arlington Ave., Toledo, OH

43614, 419–381–5213

Medlab Clinical Testing, Inc., 212

Cherry Lane, New Castle, DE 19720,

302–655–5227

MedTox Laboratories, Inc., 402 W.

County Rd. D, St. Paul, MN 55112,

800–832–3244 / 612–636–7466

Methodist Hospital Toxicology Services

of Clarian Health Partners, Inc.,

Department of Pathology and

Laboratory Medicine, 1701 N. Senate

Blvd., Indianapolis, IN 46202, 317–

929–3587

Methodist Medical Center Toxicology

Laboratory, 221 N.E. Glen Oak Ave.,

Peoria, IL 61636, 800–752–1835 /

309–671–5199

MetroLab-Legacy Laboratory Services,

235 N. Graham St., Portland, OR

97227, 503–413–4512, 800–237–7808

(x4512)

Minneapolis Veterans Affairs Medical

Center, Forensic Toxicology

Laboratory, 1 Veterans Drive,

Minneapolis, Minnesota 55417, 612–

725–2088

National Toxicology Laboratories, Inc.,

1100 California Ave., Bakersfield, CA

93304, 805–322–4250

Northwest Toxicology, Inc., 1141 E.

3900 South, Salt Lake City, UT 84124,

800–322–3361 / 801–268–2431

Oregon Medical Laboratories, P.O. Box

972, 722 East 11th Ave., Eugene, OR

97440–0972, 541–341–8092

Pacific Toxicology Laboratories, 1518

Pontius Ave., Los Angeles, CA 90025,

310–312–0056, (Formerly: Centinela

Hospital Airport Toxicology

Laboratory

Pathology Associates Medical

Laboratories, 11604 E. Indiana,

Spokane, WA 99206, 509–926–2400 /

800–541–7891

PharmChem Laboratories, Inc., 1505-A

O’Brien Dr., Menlo Park, CA 94025,

415–328–6200 / 800–446–5177

PharmChem Laboratories, Inc., Texas

Division, 7606 Pebble Dr., Fort Worth,

TX 76118, 817–595–0294 (formerly:

Harris Medical Laboratory)

Physicians Reference Laboratory, 7800

West 110th St., Overland Park, KS

66210, 913–339–0372 / 800–821–3627

Poisonlab, Inc., 7272 Clairemont Mesa

Blvd., San Diego, CA 92111, 619–279–

2600 / 800–882–7272

Premier Analytical Laboratories, 15201

East I–10 Freeway, Suite 125,

Channelview, TX 77530, 713–457–

3784 / 800–888–4063 (formerly: Drug

Labs of Texas)

Presbyterian Laboratory Services, 1851

East Third Street, Charlotte, NC

28204, 800–473–6640

Quest Diagnostics Incorporated, 4444

Giddings Road, Auburn Hills, MI

48326, 810–373–9120/800–444–0106,

(formerly: HealthCare/Preferred

Laboratories, HealthCare/MetPath,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated,

National Center for Forensic Science,

1901 Sulphur Spring Rd., Baltimore,

MD 21227, 410–536–1485, (formerly:

Maryland Medical Laboratory, Inc.,

National Center for Forensic Science,

CORNING National Center for

Forensic Science)

Quest Diagnostics Incorporated, 4770

Regent Blvd., Irving, TX 75063, 800–

526–0947/972–916–3376, (formerly:

Damon Clinical Laboratories, Damon/

MetPath, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, 875

Greentree Rd., 4 Parkway Ctr.,

Pittsburgh, PA 15220–3610, 800–574–

2474/412–920–7733, (formerly: MedChek Laboratories, Inc., Med-Chek/

Damon, MetPath Laboratories,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated, 2320

Schuetz Rd., St. Louis, MO 63146,

800–288–7293/314–991–1311,

(formerly: Metropolitan Reference

Laboratories, Inc., CORNING Clinical

Laboratories, South Central Division)

Quest Diagnostics Incorporated, 7470

Mission Valley Rd., San Diego, CA

92108–4406, 800–446–4728/619–686–

3200, (formerly: Nichols Institute,

Nichols Institute Substance Abuse

Testing (NISAT), CORNING Nichols

Institute, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, One

Malcolm Ave., Teterboro, NJ 07608,

201–393–5590 , (formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratory)

Quest Diagnostics Incorporated, 1355

Mittel Blvd., Wood Dale, IL 60191,

630–595–3888, (formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratories Inc.)

Scientific Testing Laboratories, Inc. 463

Southlake Blvd., Richmond, VA

23236, 804–378–9130

Scott & White Drug Testing Laboratory,

600 S. 25th St., Temple, TX 76504,

800–749–3788/254–771–8379

S.E.D. Medical Laboratories, 500 Walter

NE, Suite 500, Albuquerque, NM

87102, 505–727–8800/800–999-LABS

SmithKline Beecham Clinical

Laboratories, 3175 Presidential Dr.,

Atlanta, GA 30340, 770–452–1590,

(formerly: SmithKline Bio-Science

Laboratories)

SmithKline Beecham Clinical

Laboratories, 8000 Sovereign Row,

Dallas, TX 75247, 214–637–7236,

(formerly: SmithKline Bio-Science

Laboratories)

SmithKline Beecham Clinical

Laboratories, 801 East Dixie Ave.,

Leesburg, FL 34748, 352–787–9006,

(formerly: Doctors & Physicians

Laboratory)

SmithKline Beecham Clinical

Laboratories, 400 Egypt Rd.,

Norristown, PA 19403, 800–877–

7484/610–631–4600, (formerly:

SmithKline Bio-Science Laboratories)

SmithKline Beecham Clinical

Laboratories, 506 E. State Pkwy.,

Schaumburg, IL 60173, 847–447–

4379/800–447–4379, (formerly:

International Toxicology Laboratories)

SmithKline Beecham Clinical

Laboratories, 7600 Tyrone Ave., Van

Nuys, CA 91405, 818–989–2520/800–

877–2520

South Bend Medical Foundation, Inc.,

530 N. Lafayette Blvd., South Bend,

IN 46601, 219–234–4176

Southwest Laboratories, 2727 W.

Baseline Rd., Tempe, AZ 85283, 602–

438–8507

St. Anthony Hospital Toxicology

Laboratory, P.O. Box 205, 1000 N. Lee

St., Oklahoma City, OK 73101, 405–

272–7052

Toxicology & Drug Monitoring

Laboratory, University of Missouri

Hospital & Clinics, 2703 Clark Lane,

Suite B, Lower Level, Columbia, MO

65202, 573–882–1273

Toxicology Testing Service, Inc., 5426

N.W. 79th Ave., Miami, FL 33166,

305–593–2260

TOXWORX Laboratories, Inc., 6160

Variel Ave., Woodland Hills, CA

91367, 818–226–4373 / 800–966–

2211, (formerly: Laboratory

Specialists, Inc.; Abused Drug

Laboratories; MedTox Bio-Analytical,

a Division of MedTox Laboratories,

Inc.)

UNILAB, 18408 Oxnard St., Tarzana,

CA 91356, 800–492–0800 / 818–996–

7300, (formerly: MetWest-BPL

Toxicology Laboratory)

Universal Toxicology Laboratories, LLC,

10210 W. Highway 80, Midland,

Texas 79706, 915–561–8851 / 888–

953–8851
60100 Federal Register / Vol. 62, No. 215 / Thursday, November 6, 1997 / Notices

UTMB Pathology-Toxicology

Laboratory, University of Texas

Medical Branch, Clinical Chemistry

Division, 301 University Boulevard,

Room 5.158, Old John Sealy,

Galveston, Texas 77555–0551, 409–

772–3197

The Standards Council of Canada

(SCC) Laboratory Accreditation Program

for Substances of Abuse (LAPSA) has

been given deemed status by the

Department of Transportation. The SCC

has accredited the following Canadian

laboratories for the conduct of forensic

urine drug testing required by

Department of Transportation

regulations:

Dynacare Kasper Medical Laboratories,

14940–123 Ave., Edmonton, Alberta,

Canada T5V 1B4, 800–661–9876 /

403–451–3702

MAXXAM Analytics Inc., 5540

McAdam Rd., Mississauga, ON,

Canada L4Z 1P1, 905–890–2555

(formerly: NOVAMANN (Ontario)

Inc.)

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 97–29414 Filed 11–5–97; 8:45 am]

BILLING CODE 4160–20–U

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

Notice of Availability and Pubic

Comment Period on Draft Protocols for

Scientific Studies To Be Performed at

Ward Valley, California

AGENCY: Bureau of Land Management,

DOI.

ACTION: Notice of 30 day public

comment period.

SUMMARY: The Department of Interior

(DOI) and Bureau of Land Management

(BLM) announce the availability of draft

Sampling Protocols for scientific studies

to be performed at the Ward Valley site,

The draft Sampling Protocols have been

prepared pursuant to a contract with

BLM by two scientists who served on a

National Academy of Sciences (NAS)

panel on Ward Valley. The NAS panel

made recommendations in 1995 that

provide the basis for testing and

analysis of tritium and related

substances. The testing is intended to

investigate the extent to which tritium

released into the atmosphere in the

1950’s and 1960’s has migrated below

the surface of the soil at the Ward Valley

site.

DATES: Public comments on the draft

Sampling Protocols must be received by

December 8, 1997.

ADDRESSES: Copies of the draft

Sampling Protocols may be obtained

upon request. Submit requests to: Ward

Valley Project Coordinator, 2135 Butano

Drive, Sacramento. CA 95825–0451. The

draft Sampling Protocols are available

on the Internet at: www.ca.blm.gov.

FOR FURTHER INFORMATION CONTACT:

Jack Mills, Contract Officer

Representative, U.S.D.I., Bureau of Land

Management, California State Office,

2135 Butano Drive, Sacramento,

California 95825, tel: (916) 978–4636.

SUPPLEMENTARY INFORMATION: DOI and

BLM are preparing a Supplemental

Environmental Impact Statement (SEIS)

on a proposed land transfer to the State

of California for the purpose of

developing a low-level radioactive

waste facility at Ward Valley. The site

of the proposed federal transfer is

located in San Bernardino County,

California, approximately 20 miles west

of the City of Needles. Following receipt

and consideration of comments, it is

intended that Sampling Protocols will

be finalized and testing carried out

pursuant to the final Sampling

Protocols. The proposed testing is

subject is subject to an environmental

assessment (EA) prepared pursuant to

the National Environmental Policy Act.

The EA is being released for public

review and comment on this date. In

addition to this opportunity to review

the draft protocol and comment under

this notice, the public will also have the

opportunity to review and comment on

the results of the tritium, and related

materials testing and analysis in the

draft SEIS.

Duane A. Marti,

Acting Deputy State Director for Natural

Resource.

[FR Doc. 97–29233 Filed 11–5–97; 8:45 am]

BILLING CODE 4310–40–P–M

DEPARTMENT OF THE INTERIOR

Bureau of Land Management

Notice of Availability and Public

Comment Period on Environmental

Assessment (EA) of Tritium and

Related Materials Testing on Public

Lands in Ward Valley, San Bernardino

County, California

AGENCY: California State Office, Bureau

of Land Management, DOI.

ACTION: Notice of 30 day public

comment period.

SUMMARY: The Department of the

Interior (DOI), Bureau of Land

Management (BLM) has prepared an EA

of proposed plans regarding tritium and

related materials testing in Ward Valley.

The proposed plans were separately

prepared by DOI/BLM and the State of

California, Department of Health

Services.

EFFECTIVE DATE: Public comments on the

EA must be received by December 8,

1997.

SUPPLEMENTARY INFORMATION: The

purpose of this comment period is to

ensure that the public has sufficient

opportunity to review and comment on

all pertinent information on the impacts

associated with separate federal and

state proposals for testing for tritium

and related materials in Ward Valley.

The testing for tritium and related

materials will be carried out to

effectuate the recommendations of a

National Academy of Sciences panel.

Data obtained from the federal sampling

and analysis, and from the State’s if

available, will be included in a draft

Supplemental Environmental Impact

Statement (SEIS), analyzing the

proposed transfer of federal land to the

State of California for construction of a

Low-Level Radioactive Waste Disposal

Facility.

ADDRESSES: Copies of the EA may be

obtained upon request. Submit requests

to: Ward Valley Project Coordinator,

2135 Butano Drive, Sacramento, CA

95825–0451. The EA is available on the

Internet at: www.ca.blm.gov.

FOR FURTHER INFORMATION CONTACT: Jack

Mills, Contract Officer Representative,

U.S.D.I., Bureau of Land Management,

California State Office, 2135 Butano

Drive, Sacramento, California 95825, tel:

(916) 978–4636.

Duane A. Marti,

Acting Deputy State Director for Natural

Resources.

[FR Doc. 97–29234 Filed 11–5–97; 8:45 am]

BILLING CODE 4310–40–P–M

INTERNATIONAL TRADE

COMMISSION

[Investigation 332–387]

North American Free Trade

Agreement: Probable Economic Effect

on U.S. Industries and Consumers of

Accelerated Elimination of U.S. Tariffs

on Certain Articles From Mexico,

Round Two

AGENCY: United States International

Trade Commission.

ACTION: Institution of investigation and

scheduling of public hearing.

EFFECTIVE DATE: October 30, 1997.

SUMMARY: Following receipt on October

20, 1997, of a request from the Office of

the United States Trade Representative